V. Macias

100% peer review in radiation oncology: is it feasible?

J. Pérez-Calatayud, F. Lliso, A. Conde-Moreno, 2020, Clinical and Translational Oncology.

Initial experience with stereotactic body radiation therapy for localized prostate cancer using helical tomotherapy

L. Pérez-Romasanta, V. Macias, M. L. Blanco, 2014, Clinical and Translational Oncology.

Ultra‐hypofractionated radiation therapy for unfavourable intermediate‐risk and high‐risk prostate cancer is safe and effective: 5‐year outcomes of a phase II trial

I. Barrera-Mellado, V. Macias, 2019, BJU international.

A Phase II Study of Stereotactic Body Radiation Therapy for Low-Intermediate-High-Risk Prostate Cancer Using Helical Tomotherapy: Dose-Volumetric Parameters Predicting Early Toxicity

Rafael García, V. Macias, M. L. Blanco, 2014, Front. Oncol..

Laparotomy wound recurrence of endometrial carcinoma.

P. Gabriele, B. Baiotto, F. Munoz, 2003, Gynecologic oncology.

Feasibility of Intensity-Modulated Radiation Therapy in the Treatment of Advanced Cervical Chordoma

S. Chauvie, M. Stasi, P. Gabriele, 2003, Tumori.

Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials

Víctor Macías, Albert Biete, A. Biete, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Spanish Society of Radiation Oncology clinical guidelines for stereotactic body radiation therapy in lymph node oligometastases

A. Conde-Moreno, J. López-Torrecilla, V. Macias, 2016, Clinical and Translational Oncology.

Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials

A. Biete, V. Macias, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.